Atossa Therapeutics, Inc. (NASDAQ:ATOS) Sees Large Decrease in Short Interest
I'm PortAI, I can summarize articles.
Atossa Therapeutics, Inc. (NASDAQ:ATOS) experienced a significant 29.3% decrease in short interest in December, dropping to 8,200,000 shares from 11,600,000 shares in November. The current short-interest ratio is 11.6 days based on an average daily volume of 705,500 shares. Analysts have mixed views, with HC Wainwright and Ascendiant Capital maintaining a "buy" rating and a target price of $7.00, while StockNews.com downgraded the stock to "sell." Atossa's stock opened at $0.98, with a market cap of $123.42 million and a P/E ratio of -4.46.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments